Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer

被引：13

作者：

Hou, Peng ^{[1
]}

Xing, Mingzhao ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Baltimore, MD 21287 USA

来源：

CELL CYCLE | 2006年 / 5卷 / 17期

关键词：

Germline mutations; MAP Kinase pathway; BRAF gene; RAS genes; MEK genes; single nucleotide polymorphisms; Familial nonmedullary thyroid cancer (FNMTC);

D O I：

10.4161/cc.5.17.3190

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：2036 / 2039

页数：4

共 21 条

[1] Familial nonmedullary thyroid cancer. [J].

Alsanea O. .

Current Treatment Options in Oncology, 2000, 1 (4) :345-351

[2] Germline mutations in HRAS proto-oncogene cause Costello syndrome [J].

Aoki, Y ;

Niihori, T ;

Kawame, H ;

Kurosawa, K ;

Filocamo, M ;

Kato, K ;

Suzuki, Y ;

Kure, S ;

Matsubara, Y .

NATURE GENETICS, 2005, 37 (10) :1038-1040

[3] The molecular basis of thyroid epithelial tumorigenesis [J].

Bongarzone, I ;

Pierotti, MA .

TUMORI, 2003, 89 (05) :514-516

[4] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

[5]

GROSSMAN RF, 1995, ARCH SURG-CHICAGO, V130, P892

[6] The Ras-Raf-MEK-ERK pathway in the treatment of cancer [J].

Hilger, RA ;

Scheulen, ME ;

Strumberg, D .

ONKOLOGIE, 2002, 25 (06) :511-518

[7] Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene [J].

Kraimps, JL ;

Canzian, F ;

Jost, C ;

Menet, E ;

Amati, P ;

Levillian, P ;

Harach, R ;

Lesueur, F ;

Barbier, J ;

Romeo, G ;

Bonneau, D .

SURGERY, 1999, 126 (06) :1188-1194

[8] Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome [J].

Malchoff, CD ;

Sarfarazi, M ;

Tendler, B ;

Forouhar, F ;

Whalen, G ;

Joshi, V ;

Arnold, A ;

Malchoff, DM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1758-1764

[9] The genetics of hereditary nonmedullary thyroid carcinoma [J].

Malchoff, CD ;

Malchoff, DM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (06) :2455-2459

[10] Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21 [J].

McKay, JD ;

Lesueur, F ;

Jonard, L ;

Pastore, A ;

Williamson, J ;

Hoffman, L ;

Burgess, J ;

Duffield, A ;

Papotti, M ;

Stark, M ;

Sobol, H ;

Maes, B ;

Murat, A ;

Kääriäinen, H ;

Bertholon-Grégoire, M ;

Zini, M ;

Rossing, MA ;

Toubert, ME ;

Bonichon, F ;

Cavarec, M ;

Bernard, AM ;

Boneu, A ;

Leprat, F ;

Haas, O ;

Lasset, C ;

Schlumberger, M ;

Canzian, F ;

Goldgar, DE ;

Romeo, G .

AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 69 (02) :440-446

← 1 2 3 →